Four Strategic Emerging Industries-Biomedicine and Health

Development Foundation

Xiamen, designated as a National Torch Program Base for Biotechnology and New Medicine, boasts a robust biomedical and healthcare industry encompassing nine areas: innovative drugs, high-performance medical devices, high-value functional foods, biological manufacturing and breeding, emerging marine biotechnology, and more. The city’s biomedical industry is recognized as a national strategic emerging industry cluster. In 2024, the sector is projected to reach RMB 84 billion in output value, with over 1,600 companies. Xiamen is home to notable achievements such as the world’s first hepatitis E vaccine, China’s first long-acting interferon (Peginterferon), the world’s third and China’s first bivalent cervical cancer vaccine, and China’s first domestically produced Boron Neutron Capture Therapy (BNCT) cancer treatment equipment. Key players in this sector include Innovax Biotech, Amoytop Biotech, Double Medical, InTech Products, Kingdomway, AmoyDx, LP Pharma, DS Biotech, Zeesan Biotech, HITECK, KingMed Diagnostics, Hybribio Medical Laboratory, and Neuboron.

Development Priorities

• Innovative Drugs and Advanced Formulations: Novel vaccines, recombinant protein drugs, antibody drugs, microecological preparations, peptide drugs, innovative small molecule drugs, small nucleic acid drugs, and advanced modified formulations;
• Medical Devices: In-vitro diagnostic reagents and core materials (immunodiagnostics, molecular diagnostics, Point-of-Care Testing [POCT]), new-generation automated diagnostic equipment; high-performance medical devices (artificial organs, advanced cardiovascular devices, orthopedic supplies, medical imaging equipment, and tumor treatment equipment); telemedicine equipment, smart medical systems, and health equipment;
• Cutting-Edge Biomedical Technologies: AI in biomedicine, interdisciplinary life sciences technologies, cancer immunotherapy, cell therapy, and gene therapy;
• Biomedical Industry Services: Third-party testing services (including professional medical testing laboratories, medical imaging diagnostic centers, and pathological diagnostic centers) and other biomedical contract services (CXO);
• Emerging Fields: Marine biotechnology, high-value functional foods and cosmetics, health services, and biological manufacturing and breeding;
• Traditional Chinese Medicine.

• Xiamen Bio Bay (Haicang): Xiamen Biomedical Incubator; Xiamen Biomedical Pilot and Industrialization Base; Xiamen Biomedical Industrial Park; Xiamen Collaborative Center of Biomedical Innovation & Entrepreneurship; Biomedical Phase V Park; Xiamen Medical Device Industrial Park; Xiamen Biomedicine R&D Innovation Park
• Other areas: Xiang’an Digital Economy Industrial Park; Xiamen Torch Biomedical Incubator; Xiang’an Innovation Lab Supporting Industrial Park (in preparation)

Source: Xiamen Investment Handbook